Try digitalPLUS for 10 days for only $0.99


Pharmaceutical Industry
Big pharma should support the NIH
Big pharma should support the NIH

Recently at a reception, one of my faculty colleagues at Johns Hopkins expressed concern about her academic future. The pay line for National Institutes of Health (NIH) grants in her field was 7 percent; that means that she has to spend two or three weeks writing a proposal that has only a 7 percent chance of getting funded. Assuming she must write 14 proposals to get one funded (a 7 percent rate), then she will be spending her entire year writing proposals and not actually doing the work. Because of this low acceptance rate, she is evaluating her options about remaining a researcher after having gotten many NIH grants and having written over 60 peer reviewed articles in major journals. ...